{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-076869","form_type":"8-K","ticker":"BRKR","cik":"0001109354","company_name":"BRUKER CORP","filed_at":"2022-03-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.447739+00:00","generated_at":"2026-06-26T22:15:16.649150+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Bruker appoints Philip Ma to board; director Marc Kastner to retire at 2023 meeting","bullets":["Philip Ma appointed to board effective April 1, 2022, filling newly created Class II vacancy.","Marc Kastner will retire and not stand for re-election at 2023 annual meeting; continues serving until then.","Ma is CEO/founder of PrognomiQ, in which Bruker made $12M minority investment in February 2022.","Ma's background includes multiomics, life science tools, and biopharma; will serve as non-employee director."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-076869","json":"https://secwatch.observer/filing/0001193125-22-076869.json","markdown":"https://secwatch.observer/filing/0001193125-22-076869.md","text":"https://secwatch.observer/filing/0001193125-22-076869.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1109354/000119312522076869/0001193125-22-076869-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1109354/000119312522076869/d333656d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T22:15:16.649150+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"11cd2737e0","claim":"Marc Kastner departed as Director at BRUKER CORP.","evidence_excerpt":"Dr. Marc Kastner informed the Board of Directors (“Board”) of Bruker Corporation (the “Company”) of his decision to retire and not to stand for re-election as a Class II director when his current term expires at the Company’s 2023 Annual Meeting of Stockholders","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1109354/000119312522076869/0001193125-22-076869-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire and not stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"57ea677edc","claim":"Philip Ma was appointed as Director at BRUKER CORP.","evidence_excerpt":"the Board approved an increase in the number of directors to expand the size of the Board by one director to a total of eleven directors, with such additional director assigned to Class II, and appointed Dr. Philip Ma to fill the newly created vacancy on the Board, effective as of April 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1109354/000119312522076869/0001193125-22-076869-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}